Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

336 ARTÍCULOS , VIENDO DEL 181 AL 195

Alzheimer's disease and age-related memory decline (preclinical)

Terry AV Jr, Callahan PM, Hall B, Webster SJ.

Pharmacol Biochem Behav. 2011 Aug;99(2):190-210. doi: 10.1016/j.pbb.2011.02.002. Epub 2011 Feb 24.

Systems biology of Alzheimer's disease: how diverse molecular changes result in memory impairment in AD

Juhász G, Földi I, Penke B.

Neurochem Int. 2011 Jun;58(7):739-50. doi: 10.1016/j.neuint.2011.02.008. Epub 2011 Feb 17.

A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease

Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C.

Dement Geriatr Cogn Disord. 2011;31(2):158-64. doi: 10.1159/000324438. Epub 2011 Feb 19.

Sublingual sufentanil for incident pain and dementia-related response agitation

Passmore MJ.

Int Psychogeriatr. 2011 Jun;23(5):844-6. doi: 10.1017/S1041610211000275. Epub 2011 Feb 25.

Supporting autobiographical memory in patients with Alzheimer's disease using smart phones

De Leo G, Brivio E, Sautter SW.

Appl Neuropsychol. 2011 Jan;18(1):69-76. doi: 10.1080/09084282.2011.545730.

[Early onset Alzheimer's disease - diagnosis, therapy and management]

Natale B, Wohlrab D, Förtsch B, Kurz A, Diehl-Schmid J.

Fortschr Neurol Psychiatr. 2011 Mar;79(3):144-51. doi: 10.1055/s-0029-1245811. Epub 2011 Mar 10.

[Diabetes mellitus and Alzheimer's disease]

Salacz P, Csibri E.

Orv Hetil. 2011 Mar 27;152(13):512-5. doi: 10.1556/OH.2011.29071.

Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype

Jayadev S, Nochlin D, Poorkaj P, Steinbart EJ, Mastrianni JA, Montine TJ, Ghetti B, Schellenberg GD, Bird TD, Leverenz JB.

Ann Neurol. 2011 Apr;69(4):712-20. doi: 10.1002/ana.22264. Epub 2011 Mar 17.

Capacity of the Catalan and Spanish versions of the Bilingual Aphasia Test to distinguish between healthy aging, mild cognitive impairment and Alzheimer's disease

Gómez-Ruiz I, Aguilar-Alonso A.

Clin Linguist Phon. 2011 Jun;25(6-7):444-63. doi: 10.3109/02699206.2011.560989. Epub 2011 Mar 31.

Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.

CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.

Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease

Darby D, Brodtmann A, Woodward M, Budge M, Maruff P.

Int Psychogeriatr. 2011 Nov;23(9):1376-85. doi: 10.1017/S1041610211000354. Epub 2011 Apr 11.

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K.

J Alzheimers Dis. 2011;25(4):679-94. doi: 10.3233/JAD-2011-100999.

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555. Epub 2011 Apr 14.

Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease

Förster S, Buschert VC, Buchholz HG, Teipel SJ, Friese U, Zach C, la Fougere C, Rominger A, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;25(4):695-706. doi: 10.3233/JAD-2011-100996.

Alzheimer's disease: genetic basis and amyloid imaging as endophenotype

Berti V, Nacmias B, Bagnoli S, Sorbi S.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias